Literature DB >> 33090263

Successful myeloablative unrelated bone marrow transplantation for relapsed intravascular large B cell lymphoma after autologous peripheral blood stem cell transplantation.

Yoko Miura1, Jun Ooi2, Takuji Matsuo1, Tadashi Yamamoto1, Ritsu Sumiyoshi1, Sumiko Saito1, Kensuke Matsumoto1, Haruko Tashiro1, Naoki Shirafuji1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 33090263     DOI： 10.1007/s00277-020-04315-9

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  8 in total

1.  Central nervous system involvement in intravascular large B-cell lymphoma: a retrospective analysis of 109 patients.

Authors:  Kazuyuki Shimada; Takuhei Murase; Kosei Matsue; Masataka Okamoto; Naoaki Ichikawa; Norifumi Tsukamoto; Nozomi Niitsu; Hiroshi Miwa; Hideki Asaoku; Hiroshi Kosugi; Ako Kikuchi; Morio Matsumoto; Yoshio Saburi; Yasufumi Masaki; Kazuhito Yamamoto; Motoko Yamaguchi; Shigeo Nakamura; Tomoki Naoe; Tomohiro Kinoshita
Journal:  Cancer Sci       Date:  2010-03-06       Impact factor: 6.716

2.  Reduced-intensity unrelated cord blood transplantation for patients with advanced malignant lymphoma.

Authors:  Koichiro Yuji; Shigesaburo Miyakoshi; Daisuke Kato; Yuji Miura; Tomohiro Myojo; Naoko Murashige; Yukiko Kishi; Kazuhiro Kobayashi; Eiji Kusumi; Hiroto Narimatsu; Tamae Hamaki; Tomoko Matsumura; Masahiro Kami; Takahiro Fukuda; Shigeru Masuo; Kazuhiro Masuoka; Atsushi Wake; Junichi Ueyama; Akiko Yoneyama; Ko Miyamoto; Haruhisa Nagoshi; Michio Matsuzaki; Shinichi Morinaga; Yoshitomo Muto; Yoichi Takeue; Shuichi Taniguchi
Journal:  Biol Blood Marrow Transplant       Date:  2005-04       Impact factor: 5.742

3.  Outcome of patients receiving consolidative autologous peripheral blood stem cell transplantation in the frontline treatment of intravascular large B-cell lymphoma: Adult Lymphoma Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Authors:  Koji Kato; Takehiko Mori; Sung-Won Kim; Masashi Sawa; Tomoyuki Sakai; Hisako Hashimoto; Jun Taguchi; Tatsuo Oyake; Shingo Kurahashi; Kazunori Imada; Hitoshi Ohno; Junji Tanaka; Tatsuo Ichinohe; Yoshiko Atsuta; Ritsuro Suzuki; Junji Suzumiya
Journal:  Bone Marrow Transplant       Date:  2019-02-26       Impact factor: 5.483

Review 4.  Intravascular large B-cell lymphoma: a chameleon with multiple faces and many masks.

Authors:  Maurilio Ponzoni; Elias Campo; Shigeo Nakamura
Journal:  Blood       Date:  2018-08-15       Impact factor: 22.113

5.  Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation.

Authors:  Timothy S Fenske; Kwang W Ahn; Tara M Graff; Alyssa DiGilio; Qaiser Bashir; Rammurti T Kamble; Ernesto Ayala; Ulrike Bacher; Jonathan E Brammer; Mitchell Cairo; Andy Chen; Yi-Bin Chen; Saurabh Chhabra; Anita D'Souza; Umar Farooq; Cesar Freytes; Siddhartha Ganguly; Mark Hertzberg; David Inwards; Samantha Jaglowski; Mohamed A Kharfan-Dabaja; Hillard M Lazarus; Sunita Nathan; Attaphol Pawarode; Miguel-Angel Perales; Nishitha Reddy; Sachiko Seo; Anna Sureda; Sonali M Smith; Mehdi Hamadani
Journal:  Br J Haematol       Date:  2016-03-15       Impact factor: 6.998

6.  Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas.

Authors:  Stephen J Schuster; Jakub Svoboda; Elise A Chong; Sunita D Nasta; Anthony R Mato; Özlem Anak; Jennifer L Brogdon; Iulian Pruteanu-Malinici; Vijay Bhoj; Daniel Landsburg; Mariusz Wasik; Bruce L Levine; Simon F Lacey; Jan J Melenhorst; David L Porter; Carl H June
Journal:  N Engl J Med       Date:  2017-12-10       Impact factor: 91.245

Review 7.  Review of intravascular lymphoma with a report of treatment with allogenic peripheral blood stem cell transplant.

Authors:  David N Adam; Kathryn M Beleznay; Roop S Randhawa; Monica Marton; Youwen Zhou
Journal:  Cutis       Date:  2008-10

8.  Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial.

Authors:  Kazuyuki Shimada; Motoko Yamaguchi; Yoshiko Atsuta; Kosei Matsue; Keijiro Sato; Shigeru Kusumoto; Hirokazu Nagai; Jun Takizawa; Noriko Fukuhara; Koji Nagafuji; Kana Miyazaki; Eiichi Ohtsuka; Masataka Okamoto; Yasumasa Sugita; Toshiki Uchida; Satoshi Kayukawa; Atsushi Wake; Daisuke Ennishi; Yukio Kondo; Tohru Izumi; Yoshihiro Kin; Kunihiro Tsukasaki; Daigo Hashimoto; Masaaki Yuge; Atsumi Yanagisawa; Yachiyo Kuwatsuka; Satoko Shimada; Yasufumi Masaki; Nozomi Niitsu; Hitoshi Kiyoi; Ritsuro Suzuki; Takashi Tokunaga; Shigeo Nakamura; Tomohiro Kinoshita
Journal:  Lancet Oncol       Date:  2020-03-11       Impact factor: 41.316
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.